No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Contraceptive Agents / adverse effects
-
Contraceptive Agents / therapeutic use*
-
Denosumab
-
Estradiol / adverse effects
-
Estradiol / analogs & derivatives
-
Estradiol / therapeutic use
-
Female
-
Humans
-
Male
-
Nandrolone / adverse effects
-
Nandrolone / analogs & derivatives*
-
Nandrolone / therapeutic use
-
Osteoporosis, Postmenopausal / drug therapy*
-
Osteoporosis, Postmenopausal / prevention & control
-
Polidocanol
-
Polyethylene Glycols / adverse effects
-
Polyethylene Glycols / therapeutic use*
-
RANK Ligand / adverse effects
-
RANK Ligand / agonists
-
RANK Ligand / therapeutic use*
-
Sclerosing Solutions / adverse effects
-
Sclerosing Solutions / therapeutic use
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Contraceptive Agents
-
RANK Ligand
-
Sclerosing Solutions
-
TNFSF11 protein, human
-
Polidocanol
-
Polyethylene Glycols
-
dienogest
-
Denosumab
-
Estradiol
-
Nandrolone